Contributions of SubQ_Solveig
User contributions·15 logged edits·page 1 of 1
Contributions by SubQ_Solveig, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,466 edits includes activity predating the current log.
- 03:26, 17 Jul 2026 (diff | hist) Missed dose 5,277 ±0 m add a second worked example at a different vial strength
- 13:04, 27 Apr 2026 (diff | hist) Tianjin Finder Chemical 14,449 ±0 m state the city and province of the registered address
- 07:52, 13 Mar 2026 (diff | hist) Triple agonist 4,269 ±0 the half-life in the lead was the terminal figure; label it as such
- 13:30, 6 Mar 2026 (diff | hist) Talk:Injection site rotation 611 +168 /* Applicability to weekly dosing */ reply
- 09:35, 22 Feb 2026 (diff | hist) Talk:Subcutaneous injection 400 +182 /* Extrapolating insulin site data */ new section
- 22:45, 14 Dec 2025 (diff | hist) Syringe dead space 15,689 +261 expand §Measured and computed magnitudes
- 02:02, 4 Nov 2025 (diff | hist) Residual solvent 5,085 ±0 m give the limit of quantitation with the signal-to-noise ratio it assumes
- 18:06, 1 Aug 2025 (diff | hist) Glucagon-like peptide-1 12,102 ±0 add a figure for the secretion time course and caption it
- 09:26, 28 Jun 2025 (diff | hist) Reconstitution of lyophilised peptides 5,243 ±0 rm a duplicated category
- 18:52, 5 Jun 2025 (diff | hist) Dose escalation schedule 4,073 ±0 m expand §Why escalation works
- 13:35, 29 Dec 2024 (diff | hist) Underfilling 2,383 +250 rm the aggregate pass-rate figure; the denominator is not knowable
- 11:45, 27 Dec 2024 (diff | hist) Insulin syringe 3,777 +130 m state that swirling rather than shaking is the handling convention, sourced
- 22:59, 23 Dec 2024 (diff | hist) ChinaPeptides 5,332 +195 close an unbalanced quotation mark
- 19:50, 12 Dec 2024 (diff | hist) Dose escalation schedule 2,748 ±0 m sentence case in headings per PP:MOS
- 19:52, 15 Oct 2024 (diff | hist) Insulin syringe 2,790 +141 add the diluent volume the example assumes